230 related articles for article (PubMed ID: 15582916)
1. Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats.
O'Shea M; Singh ME; McGregor IS; Mallet PE
J Psychopharmacol; 2004 Dec; 18(4):502-8. PubMed ID: 15582916
[TBL] [Abstract][Full Text] [Related]
2. Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats.
O'Shea M; McGregor IS; Mallet PE
J Psychopharmacol; 2006 Sep; 20(5):611-21. PubMed ID: 16714325
[TBL] [Abstract][Full Text] [Related]
3. Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour.
Llorente-Berzal A; Fuentes S; Gagliano H; López-Gallardo M; Armario A; Viveros MP; Nadal R
Addict Biol; 2011 Oct; 16(4):624-37. PubMed ID: 21521421
[TBL] [Abstract][Full Text] [Related]
4. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
Norwood CS; Cornish JL; Mallet PE; McGregor IS
Eur J Pharmacol; 2003 Mar; 465(1-2):105-14. PubMed ID: 12650839
[TBL] [Abstract][Full Text] [Related]
5. Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test.
Genn RF; Tucci S; Marco EM; Viveros MP; File SE
Pharmacol Biochem Behav; 2004 Mar; 77(3):567-73. PubMed ID: 15006468
[TBL] [Abstract][Full Text] [Related]
6. Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison.
Renard J; Krebs MO; Jay TM; Le Pen G
Psychopharmacology (Berl); 2013 Feb; 225(4):781-90. PubMed ID: 22983145
[TBL] [Abstract][Full Text] [Related]
7. Adolescent exposure to nicotine and/or the cannabinoid agonist CP 55,940 induces gender-dependent long-lasting memory impairments and changes in brain nicotinic and CB(1) cannabinoid receptors.
Mateos B; Borcel E; Loriga R; Luesu W; Bini V; Llorente R; Castelli MP; Viveros MP
J Psychopharmacol; 2011 Dec; 25(12):1676-90. PubMed ID: 20562169
[TBL] [Abstract][Full Text] [Related]
8. Chronic pubertal, but not adult chronic cannabinoid treatment impairs sensorimotor gating, recognition memory, and the performance in a progressive ratio task in adult rats.
Schneider M; Koch M
Neuropsychopharmacology; 2003 Oct; 28(10):1760-9. PubMed ID: 12888772
[TBL] [Abstract][Full Text] [Related]
9. Chronic periadolescent cannabinoid treatment enhances adult hippocampal PSA-NCAM expression in male Wistar rats but only has marginal effects on anxiety, learning and memory.
Higuera-Matas A; Botreau F; Miguéns M; Del Olmo N; Borcel E; Pérez-Alvarez L; García-Lecumberri C; Ambrosio E
Pharmacol Biochem Behav; 2009 Oct; 93(4):482-90. PubMed ID: 19576923
[TBL] [Abstract][Full Text] [Related]
10. Cannabinoid-induced working memory impairment is reversed by a second generation cholinesterase inhibitor in rats.
Braida D; Sala M
Neuroreport; 2000 Jun; 11(9):2025-9. PubMed ID: 10884065
[TBL] [Abstract][Full Text] [Related]
11. Effects of nicotine and a cannabinoid receptor agonist on negative contrast: distinction between anxiety and disappointment?
Genn RF; Tucci S; Parikh S; File SE
Psychopharmacology (Berl); 2004 Dec; 177(1-2):93-9. PubMed ID: 15205871
[TBL] [Abstract][Full Text] [Related]
12. Chronic nicotine alters cannabinoid-mediated locomotor activity and receptor density in periadolescent but not adult male rats.
Werling LL; Reed SC; Wade D; Izenwasser S
Int J Dev Neurosci; 2009 May; 27(3):263-9. PubMed ID: 19167478
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoids increase conditioned ultrasonic vocalisations and cat odour avoidance in rats: strain differences in drug-induced anxiety.
Arnold JC; Dielenberg RA; McGregor IS
Life Sci; 2010 Oct; 87(17-18):572-8. PubMed ID: 20875432
[TBL] [Abstract][Full Text] [Related]
14. Prolonged cannabinoid treatment results in spatial working memory deficits and impaired long-term potentiation in the CA1 region of the hippocampus in vivo.
Hill MN; Froc DJ; Fox CJ; Gorzalka BB; Christie BR
Eur J Neurosci; 2004 Aug; 20(3):859-63. PubMed ID: 15255998
[TBL] [Abstract][Full Text] [Related]
15. Behavioral effects of D3 receptor inhibition and 5-HT4 receptor activation on animals undergoing chronic cannabinoid exposure during adolescence.
Abboussi O; Said N; Fifel K; Lakehayli S; Tazi A; El Ganouni S
Metab Brain Dis; 2016 Apr; 31(2):321-7. PubMed ID: 26497809
[TBL] [Abstract][Full Text] [Related]
16. Sex differences in antinociceptive and motoric effects of cannabinoids.
Tseng AH; Craft RM
Eur J Pharmacol; 2001 Oct; 430(1):41-7. PubMed ID: 11698061
[TBL] [Abstract][Full Text] [Related]
17. Acute and residual effects in adolescent rats resulting from exposure to the novel synthetic cannabinoids AB-PINACA and AB-FUBINACA.
Kevin RC; Wood KE; Stuart J; Mitchell AJ; Moir M; Banister SD; Kassiou M; McGregor IS
J Psychopharmacol; 2017 Jun; 31(6):757-769. PubMed ID: 28093016
[TBL] [Abstract][Full Text] [Related]
18. Increased anxiety and impaired spatial memory in young adult rats following adolescent exposure to methylone.
Daniel JJ; Hughes RN
Pharmacol Biochem Behav; 2016; 146-147():44-9. PubMed ID: 27178814
[TBL] [Abstract][Full Text] [Related]
19. Cannabinoids alter recognition memory in rats.
Kosiorek P; Hryniewicz A; Bialuk I; Zawadzka A; Winnicka MM
Pol J Pharmacol; 2003; 55(5):903-10. PubMed ID: 14704485
[TBL] [Abstract][Full Text] [Related]
20. Adolescent rats find repeated Delta(9)-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure.
Quinn HR; Matsumoto I; Callaghan PD; Long LE; Arnold JC; Gunasekaran N; Thompson MR; Dawson B; Mallet PE; Kashem MA; Matsuda-Matsumoto H; Iwazaki T; McGregor IS
Neuropsychopharmacology; 2008 Apr; 33(5):1113-26. PubMed ID: 17581536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
